A Phase 2 Study of Isatuximab in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone, Followed By Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients with Multiple Myeloma and Severe Renal Impairment

被引：0

作者：

Terpos, Evangelos ^{[1
]}

Kastritis, Efstathios ^{[2
]}

Symeonidis, Argiris ^{[3
]}

Pouli, Anastasia ^{[4
]}

Delimpasi, Sosana ^{[5
]}

Katodritou, Eirini ^{[6
]}

Hatzimichael, Eleftheria ^{[7
]}

Ntanasis-Stathopoulos, Ioannis ^{[8
]}

Malandrakis, Panagiotis ^{[8
]}

Fotiou, Despina ^{[8
]}

Migkou, Magdalini ^{[8
]}

Theodorakakou, Foteini ^{[8
]}

Spiliopoulou, Vasiliki ^{[8
]}

Syrigou, Rodanthi ^{[8
]}

Eleutherakis-Papaiakovou, Evangelos ^{[2
]}

Manousou, Kyriaki ^{[9
]}

Gavriatopoulou, Maria

Dimopoulos, Meletios A. ^{[2
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Drosia, Greece

[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

[3] Univ Patras, Sch Med, Hematol Div, Dept Internal Med, Patras, Greece

[4] St Savvas Oncol Hosp, Hematol Dept, Athens, Greece

[5] Gen Hosp Evangelismos, Athens, Greece

[6] Theagenio Canc Hosp, Dept Hematol, Thessaloniki, Greece

[7] Univ Ioannina, Dept Hematol, Fac Med, Ioannina, Greece

[8] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

[9] Hlth Data Specialists, Dublin, Ireland

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-173185

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[41] Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and Dexamethasone [J].

Loncharich, Alexa J. ;

Fiala, Mark A. ;

Slade, Michael J. ;

Vickroy, Angela ;

Kavanaugh, Margaret ;

Wilson, Carmen ;

Schroeder, Mark A. ;

Stockerl-Goldstein, Keith ;

Vij, Ravi ;

Sanfilippo, Kristen M. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11) :825-828

[42] Venous Thromboembolism Risk in Patients with Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination with Lenalidomide and Dexamethasone [J].

Loncharich, Alexa J. ;

Fiala, Mark A. ;

Slade, Michael J. ;

Vickroy, Angela ;

Kavanaugh, Margaret ;

Wilson, Kari ;

Schroeder, Mark A. ;

Stockerl-Goldstein, Keith E. ;

Vij, Ravi ;

Sanfilippo, Kristen M. .

BLOOD, 2022, 140 :8550-8551

[43] A Comparison of Cyclophosphamide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma [J].

Figueiredo, Amarilis ;

Atkins, Harold ;

Mallick, Ranjeeta ;

Kekre, Natasha ;

Kew, Andrea ;

McCurdy, Arleigh .

BLOOD, 2016, 128 (22)

[44] Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation [J].

Crusoe, Edvan De Queiroz ;

Higashi, Fabiana ;

Martinez, Gracia ;

Bittencourt, Rosane ;

Pinto Neto, Jorge Vaz ;

Sousa, Lais ;

Santucci, Rodrigo ;

Pessoa Magalhaes, Roberto Jose ;

Colli, Gilberto ;

Marques Nunes, Renata Ferreira ;

Ribeiro, Glaciano ;

Nicacio, Jandir ;

Zanella, Karla Richter ;

Kutner, Jose Mauro ;

Magalhaes, Andre ;

Leao, Danielle ;

Hallack Neto, Abrahao Elias ;

Braga, Walter ;

Souza, Emanuella G. ;

Guimaraes, Antonio Julio A. M. ;

Durigon, Giovanna Steffenello ;

Laks, Dani ;

Maiolino, Angelo ;

de Moraes Hungria, Vania Tietsche .

HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (02) :118-124

[45] Real World Treatment Outcomes and Cost Among Newly-Diagnosed Multiple Myeloma Patients Treated with Bortezomib and Dexamethasone in Combination with Cyclophosphamide or Lenalidomide [J].

Xie, Lin ;

Parikh, Kejal ;

Abouzaid, Safiya ;

Pandya, Shivani ;

Baser, Onur ;

Patel, Manali I. .

BLOOD, 2016, 128 (22)

[46] Bortezomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma patients: a real-world study of China [J].

Xu, Jingyu ;

Yan, Wenqiang ;

Fan, Huishou ;

Liu, Jiahui ;

Du, Chenxing ;

Deng, Shuhui ;

Sui, Weiwei ;

Xu, Yan ;

Qiu, Lugui ;

An, Gang .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 :S159-S159

[47] Isatuximab-carfilzomib-dexamethasone immediately after failing of the quadruplet Daratumumab-bortezomib-lenalidomide-dexamethasone (Dara-VRD): Striking response with no washout in a newly diagnosed multiple myeloma [J].

Gil-Fernandez, Juan Jose ;

Ramirez, Patricia Garcia ;

Charavia, Marta Callejas .

CLINICAL CASE REPORTS, 2024, 12 (01)

[48] Reduced weekly subcutaneous doses of bortezomib in combination with cyclophosphamide and dexamethasone for newly diagnosed multiple myeloma [J].

Ashrafi, Farzaneh ;

Moghaddas, Azadeh ;

Darakhshandeh, Ali .

JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2020, 9 (01) :56-59

[49] Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial [J].

Kumar, Shaji K. ;

Lacy, Martha Q. ;

Hayman, Suzanne R. ;

Stewart, Keith ;

Buadi, Francis K. ;

Allred, Jacob ;

Laumann, Kristina ;

Greipp, Philip R. ;

Lust, John A. ;

Gertz, Morie A. ;

Zeldenrust, Steven R. ;

Bergsagel, P. Leif ;

Reeder, Craig B. ;

Witzig, Thomas E. ;

Fonseca, Rafael ;

Russell, Stephen J. ;

Mikhael, Joseph R. ;

Dingli, David ;

Rajkumar, S. Vincent ;

Dispenzieri, Angela .

AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (08) :640-645

[50] Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study [J].

Bringhen, Sara ;

Petrucci, Maria Teresa ;

Larocca, Alessandra ;

Conticello, Concetta ;

Rossi, Davide ;

Magarotto, Valeria ;

Musto, Pellegrino ;

Boccadifuoco, Luana ;

Offidani, Massimo ;

Omede, Paola ;

Gentilini, Fabiana ;

Ciccone, Giovannino ;

Benevolo, Giulia ;

Genuardi, Mariella ;

Montefusco, Vittorio ;

Oliva, Stefania ;

Caravita, Tommaso ;

Tacchetti, Paola ;

Boccadoro, Mario ;

Sonneveld, Pieter ;

Palumbo, Antonio .

BLOOD, 2014, 124 (01) :63-69

← 1 2 3 4 5 →